Has Naser Alijabbari received payments from drug or device companies?

Yes. Drug and device makers reported $1,929 in general payments to Naser Alijabbari across 88 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Naser Alijabbari did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Naser Alijabbari come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Naser Alijabbari

Physician Assistant · Royal Oak, MINPI 1447941901

Payments from drug & device makers

$1,929in general payments, 2019–2025

Across 88 payments — averaging $21.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lundbeck LLC$325
Neurocrine Biosciences, Inc.$254
Otsuka America Pharmaceutical, Inc.$200
AbbVie$170
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$149
Axsome Therapeutics, Inc.$149
plus $682 from 12 others

What the payments were for

Food & beverage$1,929100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lundbeck LLC	12	$325
Neurocrine Biosciences, Inc.	11	$254
Otsuka America Pharmaceutical, Inc.	11	$200
AbbVie	11	$170
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$149
Axsome Therapeutics, Inc.	6	$149
Teva Pharmaceuticals USA, Inc.	4	$101
Alkermes, Inc.	4	$90
Johnson & Johnson	1	$88
Noven Therapeutics, LLC	4	$86
Corium, LLC	3	$61
Supernus Pharmaceuticals, Inc.	3	$59
E.r. Squibb & Sons, L.L.C.	3	$55
Orexo US, Inc.	3	$50
Takeda Pharmaceuticals U.S.A., Inc.	2	$38
Vanda Pharmaceuticals Inc.	1	$22
Tris Pharma Inc	1	$17
Getinge USA Sales, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

REXULTI$138

How this compares

$1,929 in reported general payments places this provider in the 85th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	30	$1,122
Quetiapine Fumarate	16	$597
Alprazolam	54	$451
Trazodone Hcl	33	$438
Duloxetine Hcl	20	$431
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	12	$377
Buspirone Hcl	24	$306
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	11	$284
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	17	$267
Bupropion XlBupropion Hcl	13	$170
Sertraline Hcl	21	$153
Fluoxetine Hcl	20	$64
Lorazepam	11	$27

Paid to pharmacies, not to this prescriber.

Other physician assistant in Royal Oak

Sarang PatelRoyal Oak$660K
Gabrielle DamoreRoyal Oak$200K
Laura KingRoyal Oak$63K
Inge HanschuRoyal Oak$21K
Beth SweneyAda$617K
Zainab JishiCanton$596K
Taylor HennrickAdrian$430K
Erin van DykeGrand Rapids$346K
Ashley AldridgeAnn Arbor$298K
Derek SusallaRochester Hills$242K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →